The abstract is read at the publisher; the summary is JClub's.
Mitochondrial transfer in endothelial cells is linked to improved EC bioenergetics and vascularization under pathological conditions, including ischemia, with therapeutic potential shown in early clinical trials.
- Why it matters: Vascular health depends on endothelial mitochondrial function, but damaged or dysfunctional mitochondria limit repair and angiogenesis; mitochondrial transfer is being explored to restore homeostasis.
- What they did: The review summarizes natural routes—tunneling nanotubes and extracellular vesicles—and artificial mitochondrial transplantation, focusing on how these approaches affect endothelial cell function and vascularization.
- The result: Findings suggest mitochondrial transfer can enhance EC function and support vascularization in disease models like ischemia, while clinical translation faces issues including mitochondrial instability and scaling host-derived mitochondria.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.